These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34341994)

  • 41. 17th Conference on Retroviruses and Opportunistic Infections, 16-19 February, San Francisco, CA. Treatment as prevention.
    Cohen J
    Science; 2010 Mar; 327(5970):1196-7. PubMed ID: 20203028
    [No Abstract]   [Full Text] [Related]  

  • 42. HIV treatment as prevention in men who have sex with men: examining the evidence.
    O'Byrne P; MacPherson P
    CMAJ; 2016 Feb; 188(3):198-203. PubMed ID: 26696615
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.
    Rodríguez AE; Castel AD; Parish CL; Willis S; Feaster DJ; Kharfen M; Cardenas GA; Villamizar K; Kolber M; Vázquez-Rivera L; Metsch LR
    J Acquir Immune Defic Syndr; 2013 Nov; 64 Suppl 1(0 1):S68-79. PubMed ID: 24126450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.
    Friedman SR; Wainberg MA; Drucker E
    AIDS; 1998 Nov; 12(16):2089-93. PubMed ID: 9833849
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Opravil M; Telenti A; Hirschel B; Battegay M; Vernazza P; Sudre P; Flepp M; Furrer H; Francioli P; Weber R
    Lancet; 1999 Mar; 353(9156):863-8. PubMed ID: 10093977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with perceived accuracy of the Undetectable = Untransmittable slogan among men who have sex with men: Implications for messaging scale-up and implementation.
    Rendina HJ; Parsons JT
    J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29334178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motivations and Barriers to Treatment Uptake and Adherence Among People Living with HIV in Australia: A Mixed-Methods Systematic Review.
    Mey A; Plummer D; Dukie S; Rogers GD; O'Sullivan M; Domberelli A
    AIDS Behav; 2017 Feb; 21(2):352-385. PubMed ID: 27826734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Willingness to Act upon Beliefs about 'Treatment as Prevention' among Australian Gay and Bisexual Men.
    Bavinton BR; Holt M; Grulich AE; Brown G; Zablotska IB; Prestage GP
    PLoS One; 2016; 11(1):e0145847. PubMed ID: 26741143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings.
    Waitt C; Low N; Van de Perre P; Lyons F; Loutfy M; Aebi-Popp K
    Lancet HIV; 2018 Sep; 5(9):e531-e536. PubMed ID: 29960731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Self-Reported Adherence and HIV Viral Load Suppression Among Older Children and Adolescents.
    Dziva Chikwari C; Ferrand RA; Simms V
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):e87-e89. PubMed ID: 28708812
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment as prevention: translating efficacy trial results to population effectiveness.
    Garnett GP; Becker S; Bertozzi S
    Curr Opin HIV AIDS; 2012 Mar; 7(2):157-63. PubMed ID: 22258503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using highly active antiretroviral therapy to decrease perioperative HIV-1 transmission risk.
    Spivak AM; Siliciano RF
    AIDS; 2010 Jun; 24(10):1603-4; author reply 1604. PubMed ID: 20539094
    [No Abstract]   [Full Text] [Related]  

  • 53. Multiple cofactors responsible for reducing vertical transmission with viral load and antiviral therapy as key components.
    AIDS Patient Care STDS; 1996 Dec; 10(6):377. PubMed ID: 11361564
    [No Abstract]   [Full Text] [Related]  

  • 54. Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation.
    Moreno S; Serrano-Villar S
    EBioMedicine; 2016 Nov; 13():31-32. PubMed ID: 27765640
    [No Abstract]   [Full Text] [Related]  

  • 55. The importance of being earnest. Specific advantages and new treatment options for the un-undetectable.
    Berger DS
    Posit Aware; 2007; 18(2):37. PubMed ID: 17390490
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV is sexually untransmittable when viral load is undetectable.
    Bekker LG; Smith P; Ntusi NAB
    Lancet; 2023 Aug; 402(10400):428-429. PubMed ID: 37490934
    [No Abstract]   [Full Text] [Related]  

  • 57. Current world literature.
    Curr Opin HIV AIDS; 2012 Mar; 7(2):203-9. PubMed ID: 22314405
    [No Abstract]   [Full Text] [Related]  

  • 58. The HIV Care Continuum in Small Cities of Southern New England: Perspectives of People Living with HIV/AIDS, Public Health Experts, and HIV Service Providers.
    Grau LE; Brothers S; Kim JY; Khwaja A; Heimer R; Stopka TJ
    AIDS Behav; 2021 Mar; 25(3):897-907. PubMed ID: 33001353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors influencing uptake of HIV care and treatment among children in South Africa - a qualitative study of caregivers and clinic staff.
    Yeap AD; Hamilton R; Charalambous S; Dwadwa T; Churchyard GJ; Geissler PW; Grant AD
    AIDS Care; 2010 Sep; 22(9):1101-7. PubMed ID: 20824563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacist's role in HIV care in France. Implication for clinical improvement of people living with HIV worldwide.
    Jacomet C; Langlois J; Secher S; Coban D; Lambert C; Zucman D; Trout H; Maarek R; Billaud E; Certain A
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00629. PubMed ID: 32909403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.